Clinical trials
Progression clinical trials
Below are recruiting progression clinical trials, each written for real people, not researchers. We’re tracking 716 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07764250Recruiting
Standing with distraction: balance and memory training for older adults
This study compares two types of balance and mobility training for older adults with mild to moderate memory or thinking problems. The training involves doing mental tasks while standing or walking, which may help improve both physical and cognitive function.
Islamabad, CapitalAges 55–90 - NCT07299019RecruitingPhase 3
Study of orelabrutinib for secondary progressive MS
This study tests an oral medication called orelabrutinib for people whose multiple sclerosis has changed from relapsing-remitting to secondary progressive. The goal is to see if it can slow down disability worsening that happens even without relapses.
Phoenix, ArizonaAges 18–60 - NCT05679518Recruiting
Therapy to reduce fear of cancer progression
This study tests two types of talking therapy to help people who have recently been diagnosed with advanced cancer and feel strong fear about cancer getting worse. You may be able to join if you can speak Cantonese or Mandarin and can attend a set number of therapy sessions.
Hong KongAges 18 years+ - NCT07754149Recruiting
Progressive resistance training for PMS in teen girls
This study tests whether a 6-week progressive strength training program can reduce symptoms of premenstrual syndrome (PMS) in teenage girls. It compares different exercise intensities to see what works best and may offer a drug-free way to manage PMS.
Islamabad, FederalAges 11–19 - NCT07264283Enrolling by invitationPhase 2
Testing LM11A-31 for progressive supranuclear palsy
This trial tests a drug called LM11A-31 to see if it can help people with progressive supranuclear palsy (PSP), a rare brain condition. You may join if you have had symptoms for 5 years or less, can walk with minimal help, and have good thinking abilities.
San Francisco, CaliforniaAges 41–86 - NCT07217665Enrolling by invitationPhase 2
AADvac1 vaccine for progressive supranuclear palsy
This trial tests a vaccine called AADvac1 for people with progressive supranuclear palsy (PSP), a brain condition that affects movement and thinking. The study wants to see if the vaccine can slow the disease down.
San Francisco, CaliforniaAges 41–86 - NCT04957537Recruiting
Speech and meaning therapy for primary progressive semantic aphasia
This study tests a “semantic rehabilitation” program—therapy focused on improving word meaning and understanding—for people with primary progressive semantic aphasia. If you qualify, it may help slow or improve language difficulties and daily communication.
ToulouseAges 18–100 - NCT06778174Recruiting
Treating progressive familial intrahepatic cholestasis
This study tracks treatments and outcomes for people with a confirmed genetic form of PFIC, a rare liver disease. It helps doctors learn which treatments work best for each type.
GroningenAges Any age - NCT07752992Recruiting
Online support for caregivers worried about cancer progression
This study tests a short online program to help caregivers manage their fear that the cancer will progress. It might help you feel less worried and more in control.
AarhusAges 18 years+ - NCT07067463RecruitingPhase 3
Testing orelabrutinib for primary progressive MS
This trial tests a daily pill called orelabrutinib to see if it can slow disability progression in people with primary progressive multiple sclerosis (PPMS). It may be an option for patients whose symptoms have been getting worse over the past two years.
Pheonix, ArizonaAges 18–60 - NCT06660056RecruitingPhase 1
GC001 injection for returning or growing high-grade brain tumors
This trial tests a new drug, GC001, injected directly into the tumor in people with high-grade gliomas (WHO grade 3 or 4) that have come back or are growing. It may be an option if standard treatments have stopped working.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04848740Enrolling by invitation
Tested implant for worsening thin corneas
This trial looks at whether placing a donor-like cornea “lenticule” implant can help people whose cornea is getting worse, becoming thin, and causing blurry or reduced vision. The goal is to see if the implant can improve corneal clarity and vision in progressive disease.
PristinaAges 20–60 - NCT06450470RecruitingPhase 3
Amniotic membrane after crosslinking for progressive keratoconus
This trial tests if placing a special freeze-dried amniotic membrane on the eye after crosslinking surgery helps improve healing and comfort for people with progressive keratoconus, a condition where the cornea thins and bulges.
BrestAges 18–65 - NCT07206056RecruitingPhase 1/Phase 2
Study of tulmimetostat and luxdegalutamide for advanced prostate cancer
This trial tests a new combination of two drugs for men whose prostate cancer has spread and is no longer controlled by hormone therapy. The study aims to see if this treatment can help shrink tumors or slow the disease.
Denver, ColoradoAges 18 years+ - NCT07683728Recruiting
Observational study of progressive pulmonary fibrosis (PPF) in China
This study is a registry that collects information from people in China who have progressive pulmonary fibrosis (PPF), a lung condition that gets worse over time. It aims to better understand the disease and help doctors improve care.
BeijingAges Any age - NCT07185919Recruiting
Odevixibat (Bylvay) study for PFIC patients in South Korea
This study is tracking how well odevixibat (Bylvay) works and how safe it is for people with progressive familial intrahepatic cholestasis (PFIC) in South Korea. It is for patients who are already prescribed this medicine by their doctor, and it monitors their progress over time.
GyeongsangAges Any age - NCT07512895Recruiting
Muscle Relaxation Exercises for Depression and Fatigue in Dialysis Patients
This study tests whether guided muscle relaxation exercises can reduce depression and tiredness in people undergoing hemodialysis (a blood-filtering treatment). You would learn and practice simple exercises to relax your muscles, which may help improve your mood and energy.
Istanbul, IstanbulAges 18–75 - NCT07462897Recruiting
New lens to slow nearsightedness in children
This trial tests a special eyeglass lens designed to slow down the worsening of nearsightedness (myopia) in children ages 6 to 14. It aims to keep their eyesight from getting worse quickly.
ParisAges 6–14 - NCT06920095Enrolling by invitation
Relaxation exercises for better sleep and less pain in lymphoma
This trial tests if progressive muscle relaxation exercises can help lymphoma patients sleep better, feel less tired, and have less pain. You will be guided through simple exercises using your phone.
Küçükçekmece, IstanbulAges 18 years+ - NCT06924164Recruiting
Strength training for snapping hip syndrome
This trial tests if progressive strength training can reduce pain and snapping in adults with external snapping hip. If you have a snapping or popping sensation on the outside of your hip with discomfort, this study may help find a non-surgical treatment option.
AalborgAges 18–40 - NCT07061379Recruiting
Patient feedback in first-line lung cancer treatment study
This study collects patient feedback through questionnaires to see if it helps improve outcomes for people with advanced non-small-cell lung cancer starting chemo-immunotherapy. It may help your care team better understand how you are feeling.
Milan, ItalyAges 18 years+ - NCT07588880Recruiting
Tracking Odevixibat Safety and Outcomes in PFIC Patients
This study follows patients with PFIC (a rare liver disease affecting bile flow) who are taking or planning to take odevixibat (Bylvay), a medication that helps manage the condition. Researchers will track how well the medication works, any side effects, and long-term health outcomes in Chinese patients.
BeijingAges 6 months+ - NCT06600347Recruiting
DASH diet and relaxation for heart health in menopause
This study tests whether a healthy eating plan (DASH diet) combined with a simple relaxation technique can lower heart risks in women after menopause. It may help you manage blood pressure and stress without medication.
SuezAges 50–60 - NCT07311694RecruitingPhase 3
Comparing a new treatment with standard drugs for advanced prostate cancer
This trial tests a new drug, HRS-4357, against standard treatments for men with a specific type of advanced prostate cancer that has spread and no longer responds to hormone therapy. It aims to see if the new drug works better.
Shanghai, Shanghai MunicipalityAges 18 years+
Hear when a new Progression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for progression?
- Yes. Clin2 currently lists 716 recruiting progression studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a progression trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a progression trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.